Evidence map›Paper›PMID 36982854›Full record

ArticleInternational journal of molecular sciences2023

Asymmetric Organocatalytic Mannich Reaction in the Synthesis of Hybrid Isoindolinone-Pyrazole and Isoindolinone-Aminal from Functionalized α-Amidosulfone.

Antonia Di Mola, Felice De Piano, Lorenzo Serusi, Giovanni Pierri, Laura Palombi, Antonio Massa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Antonia Di MolaDipartimento di Chimica e Biologia "A. Zambelli", Università Degli Studi di Salerno, Via Giovanni Paolo II, 84084 Fisciano, SA, Italy.
Felice De PianoDipartimento di Chimica e Biologia "A. Zambelli", Università Degli Studi di Salerno, Via Giovanni Paolo II, 84084 Fisciano, SA, Italy.
Lorenzo SerusiDipartimento di Chimica e Biologia "A. Zambelli", Università Degli Studi di Salerno, Via Giovanni Paolo II, 84084 Fisciano, SA, Italy.
Giovanni PierriDipartimento di Chimica e Biologia "A. Zambelli", Università Degli Studi di Salerno, Via Giovanni Paolo II, 84084 Fisciano, SA, Italy.ORCID 0000-0001-5433-6077
Laura PalombiDipartimento di Scienze Fisiche e Chimiche, Università dell'Aquila, 10-67100 Coppito, AQ, Italy.ORCID 0000-0002-6613-7363
Antonio MassaDipartimento di Chimica e Biologia "A. Zambelli", Università Degli Studi di Salerno, Via Giovanni Paolo II, 84084 Fisciano, SA, Italy.ORCID 0000-0003-4921-4766
University of Salerno · ITUniversity of L'Aquila · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The investigation of the reactivity of an α-amido sulfone derived from 2-formyl benzoate under organocatalytic conditions in the presence of acetylacetone allowed the synthesis of a new heterocyclic hybrid isoindolinone-pyrazole with high enantiomeric excess. Dibenzylamine was also used as a nucleophile to afford an isoindolinone with aminal substituent in 3-position in suitable selectivity. The use of Takemoto's bifunctional organocatalyst not only led to observed enantioselectivity but was also important in accomplishing the cyclization step in both cases. Notably, this catalytic system proved to be particularly effective in comparison to widely used phase transfer catalysts.

Indexed as

PyrazolesCatalysisCyclizationPhthalimidesPhthalimidesphthalimidinePyrazolesasymmetric synthesisheterocycleshybrid moleculesorganocatalysis

Identifiers

PMID36982854
PMCPMC10053823
OpenAlexW4327968173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.